Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice

Receptor binding profiles and behavioral pharmacology of ring-substituted N , N -diallyltryptamine analogs

(2018) Landon M. Klein et al.   NEUROPHARMACOLOGY

Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (“FLY”) and benzodifuran (“DragonFLY”) analogs

(2018) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N -(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT 2A Receptor Agonist

(2017) Anders A. Jensen et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation

(2017) Rainer Kraehenmann et al.   PSYCHOPHARMACOLOGY

Return of the lysergamides. Part II: Analytical and behavioural characterization ofN6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ)

(2016) Simon D. Brandt et al.   Drug Testing and Analysis

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans

(2016) Marta Valle et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

(2016) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

(2016) Stephen Ross et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effect of 5-HT 2A and 5-HT 2C receptors on temporal discrimination by mice

(2016) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues

(2015) David E. Nichols et al.   ACS Chemical Neuroscience

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)

(2015) Simon D. Brandt et al.   Drug Testing and Analysis

Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market

(2015) Asuka Kaizaki-Mitsumoto et al.   Forensic Toxicology

Synthesis and Structure–Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists

(2014) Martin Hansen et al.   ACS Chemical Neuroscience

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA/2J mice: I. Effects of D2/D3 and D2 dopamine receptor selective compounds

(2014) Claudia Rangel-Barajas et al.   NEUROPHARMACOLOGY

Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes

(2014) Bruce E. Blough et al.   PSYCHOPHARMACOLOGY

Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice

(2014) William E. Fantegrossi et al.   PSYCHOPHARMACOLOGY

New phenethylamines in Europe

(2013) L. A. King   Drug Testing and Analysis

Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on   Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations

(2013) M. Kometer et al.   JOURNAL OF NEUROSCIENCE

Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model

(2013) Clinton E. Canal et al.   NEUROPHARMACOLOGY

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response

(2013) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

Characterization of the head-twitch response induced by hallucinogens in mice

(2013) Adam L. Halberstadt et al.   PSYCHOPHARMACOLOGY

Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model

(2012) Clint E. Canal et al.   Drug Testing and Analysis

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

Interaction of 5-HT2A and 5-HT2C Receptors in R(-)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice

(2010) W. E. Fantegrossi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

(2010) Adam L Halberstadt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen

(2010) Clinton E. Canal et al.   PSYCHOPHARMACOLOGY

Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents

(2007) W FANTEGROSSI et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR